Combination Therapy with KRAS and P38 α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line

ConclusionThe current study showed that combination therapy with p38 α and KRAS siRNA may be considered a novel therapy for colorectal tumor in future.Graphical abstract

http://link.springer.com/10.1007/s12029-021-00667-1

Source: Journal of Gastrointestinal Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: research